BRIEF-AstraZeneca says no change in dividend, M&A strategy under new CFO
October 31, 2013 at 06:10 AM EDT
Oct 31 (Reuters) - AstraZeneca CEO Pascal Soriot, speaking to reporters: * CEO says new CFO Dunoyer brings blend of strategic thinking and financial